dotarem gadoteric acid 279.32mg/ml injection 5ml vial
guerbet australia pty ltd - gadoteric acid, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use in magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).
dotarem gadoteric acid 279.32mg/ml injection 10ml vial
guerbet australia pty ltd - gadoteric acid, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: water for injections; meglumine - dotarem is indicated, in adults and children, for use in magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).
dotarem gadoteric acid 279.32mg/ml injection 15ml vial
guerbet australia pty ltd - gadoteric acid, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use in magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).
dotarem gadoteric acid 279.32mg/ml injection 20ml vial
guerbet australia pty ltd - gadoteric acid, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use in magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).
magnevist
schering -
gadopentetat insight 500 mikromol/ml injektionslösung
magnegita 500 mikromol/ml injektionslösung
gadopentetat-dimeglumin sanochemia 500 mikromol/ml injektionslösung